Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation. (Q53111119)
Jump to navigation
Jump to search
scientific article published on 2 May 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation. |
scientific article published on 2 May 2013 |
Statements
Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation. (English)
1 reference
1 reference
1 reference
Christopher B Granger
1 reference
Veli-Pekka Harjola
1 reference
Lars Wallentin
1 reference
Laine Thomas
1 reference
Witold Ruzyllo
1 reference
Renato D Lopes
1 reference
John H Alexander
1 reference
Raffaele De Caterina
1 reference
Mårten Rosenqvist
1 reference
John J V McMurray
1 reference
Philip Aylward
1 reference
Sana M Al-Khatib
1 reference
Steen Husted
1 reference
Matyas Keltai
1 reference
Anne Hellkamp
1 reference
Jack Ansell
1 reference
Patrick Commerford
1 reference
Fernando Lanas
1 reference
John Amerena
1 reference
Marco Alings
1 reference
Jozef Bartunek
1 reference
John D Horowitz
1 reference
Byung-Hee Oh
1 reference
Michael Hanna
1 reference
Sunil Nepal
1 reference
Kurt Huber
1 reference
Liu Lisheng
1 reference
Dragos Vinereanu
1 reference
Denis Xavier
1 reference
Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Investigators
1 reference
2 May 2013
1 reference
1 reference
127
1 reference
2166-2176
1 reference
22
1 reference
Identifiers
1 reference